Mark P Purdue

Author PubWeight™ 133.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012 11.48
2 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010 3.93
3 Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 3.51
4 Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008 3.04
5 Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol 2008 2.80
6 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010 2.37
7 Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2010 2.28
8 Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 2013 2.21
9 Retracted Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2010 2.16
10 International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010 2.07
11 Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 2013 1.99
12 Genome-wide association study of glioma and meta-analysis. Hum Genet 2012 1.96
13 Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.95
14 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
15 Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008 1.80
16 Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology 2015 1.78
17 Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 2011 1.77
18 Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol 2013 1.73
19 Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2009 1.70
20 Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2010 1.63
21 Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev 2011 1.60
22 GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 2011 1.58
23 Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 2012 1.52
24 Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One 2009 1.52
25 Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol 2013 1.49
26 Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.40
27 A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 2011 1.36
28 Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A 2012 1.36
29 Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet 2011 1.34
30 A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet 2011 1.34
31 Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.33
32 Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet 2012 1.31
33 Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev 2010 1.27
34 A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009 1.26
35 Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.23
36 Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 2009 1.22
37 Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control 2012 1.19
38 Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 2009 1.17
39 Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.16
40 Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.12
41 Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis 2010 1.10
42 Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol 2010 1.08
43 The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet 2011 1.08
44 Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 2007 1.07
45 The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 2012 1.04
46 Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. Cytokine 2011 1.02
47 Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 2009 1.01
48 Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood 2012 1.01
49 Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 2012 1.00
50 Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One 2012 1.00
51 Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer 2014 0.99
52 One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 2007 0.98
53 The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst 2013 0.98
54 Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol 2011 0.98
55 A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood 2012 0.97
56 Impact of pesticide exposure misclassification on estimates of relative risks in the Agricultural Health Study. Occup Environ Med 2011 0.96
57 Racial difference in histologic subtype of renal cell carcinoma. Cancer Med 2013 0.96
58 Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol 2010 0.96
59 Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol 2014 0.95
60 An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control 2011 0.94
61 Telomere length and risk of glioma. Cancer Epidemiol 2013 0.94
62 Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica 2007 0.94
63 A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol 2011 0.93
64 Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2014 0.92
65 Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. Am J Epidemiol 2013 0.92
66 Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 2013 0.91
67 Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2012 0.91
68 Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2013 0.91
69 Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr 2011 0.90
70 Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev 2011 0.89
71 Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol 2010 0.89
72 A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis 2014 0.88
73 History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2011 0.87
74 Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev 2007 0.87
75 Chemical exposures and risk of chronic lymphocytic leukaemia. Br J Haematol 2007 0.86
76 A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev 2013 0.86
77 Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol 2012 0.86
78 IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol 2013 0.86
79 Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium. Environ Health Perspect 2015 0.85
80 Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control 2013 0.85
81 Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium. Eur J Epidemiol 2013 0.84
82 Alterations in serum immunoglobulin levels in workers occupationally exposed to trichloroethylene. Carcinogenesis 2012 0.84
83 LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Epigenetics 2015 0.83
84 Body mass index and renal cell cancer: the influence of race and sex. Epidemiology 2012 0.83
85 Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut. Am J Hematol 2010 0.81
86 Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Int J Cancer 2012 0.81
87 A case-control study of occupation/industry and renal cell carcinoma risk. BMC Cancer 2012 0.81
88 Assessing disease risk in genome-wide association studies using family history. Epidemiology 2012 0.80
89 A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013 0.80
90 Occupational exposure to chlorinated solvents and risks of glioma and meningioma in adults. Occup Environ Med 2012 0.79
91 Hysterectomy and kidney cancer risk: a meta-analysis. Int J Cancer 2013 0.79
92 A prospective study of alcohol consumption and renal cell carcinoma risk. Int J Cancer 2014 0.79
93 Occupational Lead Exposure and Associations with Selected Cancers: The Shanghai Men's and Women's Health Study Cohorts. Environ Health Perspect 2015 0.78
94 Workshop report: environmental exposures and cancer prevention. Environ Health Perspect 2003 0.78
95 Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma. Int J Cancer 2006 0.77
96 Occupational Exposure to Benzene and Non-Hodgkin Lymphoma in a Population-Based Cohort: The Shanghai Women's Health Study. Environ Health Perspect 2015 0.77
97 A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study. Cancer Causes Control 2013 0.77
98 Trichloroethylene and cancer. J Natl Cancer Inst 2013 0.76
99 Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma. PLoS One 2013 0.75
100 Comparison of hematological alterations and markers of B-cell activation in workers exposed to benzene, formaldehyde and trichloroethylene. Carcinogenesis 2016 0.75
101 The authors respond. Epidemiology 2015 0.75
102 Re: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2005 0.75
103 Aspirin use and mortality in two contemporary U.S. cohorts. Epidemiology 2017 0.75